Markus Zeitlinger received several grants

Congratulations to Markus Zeitlinger, head of the Department of Clinical Pharmacology and key researcher of LBI:AD’s program line Clinical Applications. He received several grants for projects within the „AMR Accelerator Program“ of the Innovative Medicine Initiative (IMI). The Initiative supports studies targeting the investigation of multi-drug resistance to antibiotics. Read more >>here<<

Scientific Advisory Board

1st Scientific Advisory Board Meeting

On February the 1st, 2018 our first Scientific Advisory Board Meeting took place. Five internationally renowned experts visited our institute with the purpose to evaluate and review our research.The meeting started with a welcome note by Vice Rector Dipl.-Ing. Dr Michaela Fritz. She emphasised the importance of personalised and translational medicine as well as the […]

LBI:AD Team

Der LBG Weinherbst 2015

Die Vorstellung des Institutes erfolgte im Rahmen des Weinherbstes der Ludwig Boltzmann Gesellschaft am 20. Oktober 2015 im Beisein des Präsidenten der Ludwig Boltzmann Gesellschaft, DI Josef Pröll.Neues Ludwig Boltzmann Institut für Angewandte Diagnostik am AKH: „Liquid Biopsies“ und „Imaging Biomarker“ werden kombiniert, um eine neue zielgerichtete Molekulare Bildgebung zu ermöglichen Der wissenschaftliche Fokus des […]